Experts advising on dietary guidelines say it's premature to tackle ultra-processed foods. "In the next five years, research ...

Most pharmaceutical executives didn't donate to political candidates in the lead-up to the election. But the ones who did ...

That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer ...

A coalition of 12 Philadelphia-area health systems have abandoned the use of race adjustments in four clinical tools ...

The emails from inside a physician practice owned by UnitedHealth Group sounded cheery, but were all business.

It is in the public’s best interest for the president and candidates to receive confidential medical care, writes ethicist ...

As we approach the start of a new year, what trends will be impacting the biotech industry in 2025? And how can biotech ...

Karen Lynch frequently spoke of how her mother's death from suicide and her aunt's death from cancer shaped her health care ...

Confounding data from a Pfizer clinical trial have rattled the field of gene therapy for Duchenne muscular dystrophy ...

Catalent, a leading contract drug manufacturer, issued an open letter Monday to reassure customers that a proposed $16.5 ...

Stillbirth. Miscarriage. Spontaneous abortion. Habitual aborters. The language of pregnancy loss is always inadequate, writes ...

A Pfizer result is unsettling the gene therapy push for Duchenne muscular dystrophy: The boys didn't improve even though a ...